Pacira | Omløpsmidler



Current Assets Endring Dato
Astellas Pharma JPY 1.2T 2.56B 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Ironwood Pharmaceuticals USD 182.42M 3.81M 2024-12
J&J USD 71.55B 15.66B 2025-03
Ligand Pharmaceuticals USD 331.56M 22.17M 2024-12
Novo Nordisk 195.16B 17.66B 2024-09
Pacira USD 745.13M 55.16M 2024-12
Perrigo USD 2.48B 1.23B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
Teva Pharmaceutical Industries USD 12.55B 238M 2024-12
Xeris Pharmaceuticals USD 167.66M 4.86M 2024-12
Zoetis USD 5.99B 296M 2024-12



Pacira Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.